Value not worth it? Pharmaceutical industry pay disclosure

Editor: Half summerthe upcoming June, is the college entrance examination season, is also the graduation seasonThis year's graduation season is destined to be extraordinaryEmployment pressure is a must for this year's graduatesAccording to the Securities Times, the total number of college graduates nationwide will reach 8.74 million in 2020, an increase of more than 400,000 from last year and a new highAffected by the outbreak, from the beginning of 2020 to April 26, the number of registered companies reached 5.2 million, the number of companies written off more than 7.15 million, the number of cancellations far exceeded the number of registered companies, employment pressure is relatively largesurvey shows that the country's 650 million netizens monthly income of less than 5000 yuan, netizens call tai-tyingWhat industry to look for, which industry wages are relatively substantial, good prospects for development, this should be a problem for all graduatesrecently, the employment competitiveness report of Chinese college students came outIt has been estimated that the average expected salary of this year's graduates is about $6,930, or nearly $7,000in this new era of change has become the norm, the diversity of the discipline settings in colleges and universities is constantly increasing, "professional counterparts" is no longer a necessary condition for young people to choose a career, whether there is a solid academic foundation and compound ability, in the process of job-hunting more and more prominentWhat are the high-paying potential industries? Which companies are the most generous? Which companies are the most key? These should be what graduates are eager to knowAccording to the Securities Times data treasure statistics show that in terms of the median per capita salary (non-executive) of employees, listed companies in the past five years of employee pay increased year by yearthe median pay for employees in 2019 reached $130,400, an increase of 8.82 percent over 2018, and the increase in compensation over the past three years has remained at around 10 percentThe overall level of employee compensation of The Company is high, with the median employee compensation in 2019 exceeding 185,000 yuanat the same time, executive pay is increasing year by year, with the median per capita executive pay in 2019 exceeding $400,000, and the same annual increase of 10%, showing that companies treat ordinary employees and executives relatively fairly , 10 industries have grown by more than 30% in the past three years compared with 2016 It is worth mentioning that the cumulative growth of pharmaceutical organisms over the past three years has exceeded 39% During this year's outbreak, anti-epidemic-related pharmaceutical companies played an important role, I believe that the pharmaceutical industry's pay this year or there will be a greater room for improvement we can see from the figure above that although the salary level of the biopharmaceutical industry is still in a moderate downstream position, but from its growth rate, it is still very promising when it comes to the pharmaceutical industry, let's take a look at the pay situation in this part of the "medical" section recently, lilac talent released the 2020 China Hospital Compensation Report The report shows that the average salary of first-tier cities reached 253,000, second- and third-tier cities 190,000, fourth-tier and other cities are 128,000, the first-tier city pay level obviously has an advantage overall, the average annual salary of medical personnel is 185,000 yuan, which is 4.35 times the average annual salary of the working staff in urban areas nationwide (425,000 yuan) From this dimension, the salaries of medical personnel are still competitive So, which departments in the hospital are paid more? Overall, oncology, cardiovascular medicine, neurology, orthopedics are high-income departments, while pediatrics and dermatology are relatively low Let's take a look at the salaries of medical representatives according to the previous article of the drug maker, a 6-year-old drug prescription revealed that after graduation, he chose the drug, but also to see the drug "high salary" this attraction some foreign companies' drug-based wages are probably as follows: Lilly , Pudai 7K-9K, GaoDai 10K plus, subsidy 1.2K ; 15% of salary, 12 salary; Merck, Pudai base salary up to 7K-8K, High End 8K plus, subsidy 2K or so, 13 salary; Sanofi, Pudai 6k-8k, High End 8K-10K, subsidy 20 00 or so, 13 salary; AstraZeneca, Big AZ, Pudai 6K-7K, Gaodai 8K or so, subsidy 4K/month or so, bonus average 10k/month, 13 salary; GlaxoSmithK.E., Pudai 9K, Gaodai 12 K-15K or so, no quarterly bonus, annual bonus is 5 months salary, subsidy 2K; Novartis, Purday 6k-8k, Gaodai 9k-12k, subsidy 1800, 12 salary; Roche, Pudai 6k-8K, Gao dai 8K-11k, subsidy 2500, telephone charges 350, 13 salaries pharmaceutical industry is a new industry, the impact of the epidemic on the pharmaceutical industry is more of a phased fluctuation, overall there is no major negative impact it is understood that during the outbreak, a number of pharmaceutical companies have also made pay increases to encourage employees, such as: Bayer: announced a pay increase of 2.9 per cent in February; AstraZeneca: announced a pay increase in February, a 6-8 per cent pay increase, to be implemented on March 1st; and Pfizer: According to employee reports, in February also announced a pay increase, pay increase ratio of 8%; stone drug anti-oncology department: the opening annual pay rise, the pay increase ratio of 10-30%; Xi'an Yangsen: According to employees, february pay increase, pay increase ratio of 6.6%; It is worth mentioning that in the prescription drug track, innovative drugs have shown strong competitiveness, with the subsequent expansion of innovative drugs on the market varieties and scale, almost all research and development innovative pharmaceutical companies will establish an internal team responsible for the academic promotion of products take PD-1 as an example, as a new category of products, need to invest a lot of academic promotion efforts to popularize the applicable population of drugs, the use of methods and adverse reactions monitoring and treatment The greater the number of academic promotion teams, the more professional it is, and the easier it is for doctors to master how their products are used this time, young, highly educated, strong learning ability of the medical representatives, will usher in a new round of career development opportunities (original title: Pharmaceutical representative pay public)